The Moving Average Convergence Divergence (MACD) for CANC turned positive on October 20, 2026. Looking at past instances where CANC's MACD turned positive, the stock continued to rise in 27 of 28 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CANC as a result. In 47 of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
Following a +4.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where CANC advanced for three days, in 172 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CANC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
CANC moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CANC crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CANC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for CANC entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator for CGON moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In 12 of the 12 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 24 of 26 cases where CGON's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CGON just turned positive on October 22, 2026. Looking at past instances where CGON's MACD turned positive, the stock continued to rise in 25 of 29 cases over the following month. The odds of a continued upward trend are 86%.
Following a +0.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where CGON advanced for three days, in 118 of 146 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
CGON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CGON as a result. In 38 of 48 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
CGON moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CGON crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for CGON entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.315) is normal, around the industry mean (3.043). P/E Ratio (-22.941) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (1000.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. CGON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
| CANC | CGON | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 74% |
| Advances ODDS (%) | 5 days ago 88% | 3 days ago 81% |
| Declines ODDS (%) | 2 days ago 83% | 11 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 74% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GVI | 103.95 | -0.09 | -0.09% |
| iShares Intermediate Government/Credit Bond ETF (GVI) | |||
| IBHG | 21.74 | -0.02 | -0.11% |
| iShares iBonds 2027 Term High Yield and Income ETF (IBHG) | |||
| YSPY | 15.08 | -0.05 | -0.35% |
| GraniteShares YieldBOOST SPY ETF (YSPY) | |||
| PIM | 2.98 | -0.02 | -0.67% |
| Picard Medical Inc | |||
| PSIL | 20.64 | -0.29 | -1.39% |
| AdvisorShares Psychedelics ETF (PSIL) | |||
A.I.dvisor indicates that over the last year, CANC has been loosely correlated with KURA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CANC jumps, then KURA could also see price increases.
| Ticker / NAME | Correlation To CANC | 1D Price Change % | ||
|---|---|---|---|---|
| CANC | 100% | -0.50% | ||
| KURA - CANC | 65% Loosely correlated | -2.54% | ||
| IMNM - CANC | 64% Loosely correlated | -1.48% | ||
| IDYA - CANC | 58% Loosely correlated | -3.90% | ||
| IMCR - CANC | 56% Loosely correlated | -3.55% | ||
| ARVN - CANC | 55% Loosely correlated | -5.44% | ||
More | ||||
A.I.dvisor indicates that over the last year, CGON has been loosely correlated with MLTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then MLTX could also see price increases.
| Ticker / NAME | Correlation To CGON | 1D Price Change % | ||
|---|---|---|---|---|
| CGON | 100% | -1.33% | ||
| MLTX - CGON | 50% Loosely correlated | -3.97% | ||
| BCAX - CGON | 47% Loosely correlated | -3.07% | ||
| IDYA - CGON | 43% Loosely correlated | -3.90% | ||
| SRRK - CGON | 43% Loosely correlated | -1.12% | ||
| ORKA - CGON | 42% Loosely correlated | -1.23% | ||
More | ||||